<DOC>
	<DOCNO>NCT01343953</DOCNO>
	<brief_summary>This Prospective Phase II Study evaluate Cord Blood Transplantation Inherited Acquired Severe Aplastic Anemia Refractory Relapse Immunosuppressive Therapy absence HLA identical donor ;</brief_summary>
	<brief_title>Cord Blood Transplantation Severe Aplastic Anemia</brief_title>
	<detailed_description>This Prospective Phase II Study evaluate Cord Blood Transplantation Inherited Acquired Severe Aplastic Anemia Refractory Relapse Immunosuppressive Therapy absence Human Leucocyte Antigen ( HLA ) identical donor ; 26 patient recruit , accord one step Fleming design</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Genetic Diseases , Inborn</mesh_term>
	<criteria>Age : 355 year old inherited aplastic anemia ( severe aplastic anemia criterion ) acquire aplastic anemia relapse treatment failure immunosuppressive therapy without clonal evolution Karnovsky Index &gt; = 60 % Informed consent HLA identical donor</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>severe aplastic anemia</keyword>
	<keyword>cord blood transplantation</keyword>
</DOC>